tretinoin   Click here for help

GtoPdb Ligand ID: 2644

Synonyms: all-trans-retinoic acid (ATRA) | Altreno® (0.05% lotion) | Avita® (0.025% gel) | Renova® (0.02% cream)
Approved drug PDB Ligand
tretinoin is an approved drug (FDA (1995))
Comment: Tretinoin is a naturally occurring derivative of vitamin A (retinoic acid) and as such is an agonist at the retinoic acid receptors. Tretinoin binds to α, β, and γ isoforms of the retinoic acid receptor. Retionoids are important regulators of cell reproduction, proliferation, and differentiation.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: tretinoin

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 37.3
Molecular weight 300.21
XLogP 6.25
No. Lipinski's rules broken 1
Click here for help
Isomeric SMILES C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C
InChI InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+
No information available.
Summary of Clinical Use Click here for help
Retinoids are used in the treatment of various skin disorders, including acne, UV damage and keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin is also used as a differentiating agent and anticancer drug in the treatment of acute promyelocytic leukemia.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
The effectiveness of tretinoin in treating indicated skin disorders appears to be due to its ability to modify abnormal follicular keratinization. The mechanism of effectiveness in treating acute promyelocytic leukemia is not fully understood.
External links Click here for help